Delivery Order SPE2DB20D3103-SPE2DB25FP5E7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,074,564 units of oseltamivir phosphate 75 mg capsules. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,779.47 and a completion date of January 29, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,394,389 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of January 23, 2024 and a ceiling value of $3,630.81. The award is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,344.25, is for the procurement of 4,565,163,595 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of July 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This contract award is for the delivery of 4,563,518,552 capsules of the pharmaceutical drug Oseltamivir Phosphate 75 mg to the Defense Logistics Agency (DLA). The $7,193.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 1, 2024. The contract has a period of performance through February 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The Firm Fixed Price Delivery Order has a ceiling value of $2,635.20 and an ultimate completion date of November 15, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,145.00 and an ultimate completion date of October 20, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,465.27, is for the delivery of Oseltamivir Phosphate 75 mg capsules. It is a Firm Fixed Price Delivery Order contract, with a period of performance through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA). The $1,955.99 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir Phosphate 75 mg capsules. The $1,318.40 firm fixed price contract does not have a set-aside designation and has an ultimate completion date of July 25, 2024. AmerisourceBergen is delivering the medication under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Oseltamivir Phosphate 75 mg capsules, a medication used to treat and prevent influenza, with a ceiling value of $50,852.35 and a performance period ending on January 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5E7Delivery Order
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the supply of 4568804826 oseltamivir phosphate 30 mg capsules. The contract has a ceiling value of $1,905.25 and a completion date of July 17, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The company holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for supplying a wide range of medical commodities to military healthcare programs. This contract award is not set-aside and was competitively awarded.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/16/25 |